PartsTable
Technical Data Sheet
Download PDF

1589173 — ENALAPRILAT INJECTION

✓ Government record, cited
— · COMPONENT
PRODUCT OVERVIEW

1589173: ENALAPRILAT INJECTION.

The ENALAPRILAT INJECTION is a the manufacturer industrial component. Key specifications include administration: INTRAVENOUS, features_provided: STERILE, primary_container_type: VIAL, SINGLE DOSE, secondary_container_type: PACKAGE, pharmaceutical_vehicle_type: AQUEOUS, total_primary_container_quantity: 10. This part is cataloged in the U.S.

Government catalog under NSN 6505-01-693-3225, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.

Verify compatibility with your specific system configuration before ordering.

WHERE IT FITS
1589173
NSN: 6505-01-693-3225
FSC: 6505 — Drugs and Biologicals
CAGE: 89875 — DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA (USA)
SPECIFICATIONS
administrationINTRAVENOUS
features_providedSTERILE
primary_container_typeVIAL, SINGLE DOSE
secondary_container_typePACKAGE
pharmaceutical_vehicle_typeAQUEOUS
total_primary_container_quantity10
primary_container_content_quantity2.0 MILLILITERS
part_name_assigned_by_controlling_agencyENALAPRILAT INJECTION, 2ML VIAL, 10S
NSN6505-01-693-3225
COMPONENT DIAGRAM
COMPONENT MAIN IC EDGE CONNECTOR No detailed specs available ENALAPRILAT INJECTION TITLE COMPONENT PN 1589173 MFR ENALAPRILAT INJECTION
KEY FEATURES
•
ADMINISTRATION: INTRAVENOUS
•
PRIMARY CONTAINER CONTENT QUANTITY: 2.0 MILLILITERS
•
SECONDARY CONTAINER TYPE: PACKAGE
•
FEATURES PROVIDED: STERILE
•
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
•
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
TECHNICAL CHARACTERISTICS
ADMINISTRATIONINTRAVENOUS
PRIMARY CONTAINER CONTENT QUANTITY2.0 MILLILITERS
SECONDARY CONTAINER TYPEPACKAGE
FEATURES PROVIDEDSTERILE
PRIMARY CONTAINER TYPEVIAL, SINGLE DOSE
SPECIAL FEATURESINDICATED FOR THE TREATMENT OF HYPERTENSION WHEN ORAL THERAPY IS NOT PRACTICAL; IS A STERILE AQUEOUS SOLUTION FOR INTRAVENOUS ADMINISTRATION ONLY; STORE AT 25 C (77 F); EXCURSIONS PERMITTED TO 15 TO 30 C (59 TO 86 F) (SEE USP CONTROLLED ROOM TEMPERATURE); 2ML; SINGLE USE VIAL; CARTON OF 10S.
PART NAME ASSIGNED BY CONTROLLING AGENCYENALAPRILAT INJECTION, 2ML VIAL, 10S
PHARMACEUTICAL VEHICLE TYPEAQUEOUS
TOTAL PRIMARY CONTAINER QUANTITY10
OTHER ITEMS IN FSC 6505 — Drugs and Biologicals
Items in the same Federal Supply class. No interchangeability or substitution relationship is implied.
6505-00-000-0073 6505-00-000-0110 6505-00-000-0134 6505-00-000-0135 6505-00-001-3344 6505-00-001-3345 6505-00-001-3346 6505-00-001-3347
SUBSTITUTES & CROSS-REFERENCES 1
6505NCM216834Reference document
Same NSN cross-reference
Reference document — Secondary reference
LIFECYCLE
NSN statusActive· U.S. Government catalog
Shelf-life managedNo demilitarization required
Ready to buy 1589173?
Compare prices from verified sellers on eBay
Buy on eBay →
As an eBay Partner, PartsTable may earn a commission. Your price is not affected.
FREQUENTLY ASKED QUESTIONS
What is 1589173?
1589173 is a ENALAPRILAT INJECTION.
What parts can replace 1589173?
There is 1 known substitute for 1589173: 6505NCM216834. Substitute compatibility should be verified for your specific system.
What is the NSN for 1589173?
1589173 is cataloged in the U.S. Government catalog under NSN 6505-01-693-3225. This indicates validated use in U.S. government and defense supply chains.
Community Feedback
Leave a Comment
Comments are reviewed before appearing. You will receive an email to verify before your comment appears.

Request a Quote — 1589173